Literature DB >> 17223043

Risk factors associated with HCV infection in semi-rural areas of central Greece.

Nikolaos K Gatselis1, Eirini Rigopoulou, Aggelos Stefos, Maria Kardasi, Georgios N Dalekos.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) appears to be endemic in most parts of the world, but there is considerable geographic variation. In order to assess the geographic distribution of HCV in Thessaly, in central Greece, we conducted a retrospective study in HCV-infected patients attending the Academic Liver Unit of Thessaly University from 1999 to 2003. We also investigated whether variation among regions could be attributed to differences in risk factors.
METHODS: We evaluated the records of 309 HCV patients whose origin and/or residence was in Thessaly. To identify risk factors that were independently associated with the place of birth and/or residence, adjusted odds ratios (OR) were calculated by logistic regression analysis. We also studied the medical records of 150 HCV-negative patients from the same areas in order to evaluate whether there are differences in risk factors reported by HCV-positive and HCV-negative patients.
RESULTS: We found three municipalities with a high HCV frequency. The use of non-disposable, multiple-use glass syringes for medical purposes in the past was the only potential risk factor more frequently identified in these areas than in other places (OR=2.3; p<0.05). This risk factor was significantly (p<0.001) associated with older age of the infected patients.
CONCLUSIONS: This study shows that the spread of HCV in the three regions may have occurred several years ago as a result of the use of multiple-use glass syringes. Differences in prevalence rates among different age groups, as well as among different areas, indicate the need for extensive studies to determine HCV epidemiology and to develop appropriate prevention programs.

Entities:  

Year:  2007        PMID: 17223043     DOI: 10.1016/j.ejim.2006.09.008

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  7 in total

1.  Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome.

Authors:  Eirini I Rigopoulou; Kalliopi Zachou; Nikolaos K Gatselis; Georgia Papadamou; George K Koukoulis; George N Dalekos
Journal:  World J Hepatol       Date:  2013-10-27

2.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

3.  Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?

Authors:  Kalliopi Zachou; Pinelopi Arvaniti; Nikolaos K Gatselis; Kalliopi Azariadis; Georgia Papadamou; Eirini Rigopoulou; George N Dalekos
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

4.  The changing epidemiology of hepatitis B in Greece.

Authors:  Eirini I Rigopoulou; Nikolaos K Gatselis; Konstantinos Galanis; Vasiliki Lygoura; Stella Gabeta; Kalliopi Zachou; George N Dalekos
Journal:  Ann Gastroenterol       Date:  2021-02-26

5.  Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series.

Authors:  Evangelia Tsironi; Nikolaos Gatselis; Maria G Kotoula; Kalliopi Zachou; Maria Pefkianaki; Fani Zacharaki; Dimitrios Z Chatzoulis; George N Dalekos
Journal:  Cases J       Date:  2009-10-20

Review 6.  Epidemiology of hepatitis C in Greece.

Authors:  Christos Triantos; Christos Konstantakis; Paraskeui Tselekouni; Maria Kalafateli; Ioanna Aggeletopoulou; Spilios Manolakopoulos
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

7.  Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.

Authors:  Nikolaos K Gatselis; Tamás Tornai; Zakera Shums; Kalliopi Zachou; Asterios Saitis; Stella Gabeta; Roger Albesa; Gary L Norman; Mária Papp; George N Dalekos
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.